Kiranam Chatti, Ph.D.
Tyrosine kinase regulation and signalling.
Education & Training
1998-2004: Ph.D. in Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson MS, USA.
2005-2008: Post-doctoral research, Dept. of Physiology & Biophysics, State University of New York, Stony Brook NY, USA
2008-2013: Senior Research Scientist, Institute of Life Sciences, Hyderabad..
2013 onwards: Principal Research Scientist and Head, Biology, Dr. reddy’s institute of Life Sciences, Hyderabad.
International Knowledge Millenium Conference 2013: ‘Lightning Pitch’ award for zebrafish technology entrepreneurship.
American Society for Pharmacology and Experimental Therapeutics (ASPET) travel award – International Union of Pharmacology (IUPHAR), San Francisco USA, July 2002.
Fisher Scientific award - Mississippi Academy of Sciences, Tupelo USA, February 2001.
Lowell M Greenbaum award - South Eastern Pharmacology Society, USA, August 2000.
All-American Scholar - United States Achievement Academy, 2000.
CSIR (Council for Scientific and Industrial Research), India - Junior Research Fellowship (JRF) - 1997.
Jawaharlal Nehru University, India - National Fellowship (for M.Sc. Biotechnology), 1995-1997.
Research in the Chatti laboratory is focused on tyrosine kinases. Specifically, regulation of the activity of the tyrosine kinase BRK/PTK6 by naturally expressed splice variants containing non-catalytic domains such as the SH3 domain, and their clinical relevance in disease is one area of work. Zebrafish as an animal model to study tyrosine kinases is a connected area of work. Research grants from CSIR, DST and DBT provide support for the above projects.
Kiranam Chatti’s Google Scholar page:
Kiranam Chatti’s Publications on pubmed:
Kiranam Chatti’s Lab Webpage: